...
机译:Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
Novartis Inst Biomed Res, Struct Biophys Grp, Chem Biol & Therapeut, CH-4002 Basel, Switzerland;
Novartis Inst Biomed Res, Novartis Biol Ctr, CH-4002 Basel, Switzerland;
Novartis Inst Biomed Res, Chem Biol & Therapeut, Cambridge, MA 02139 USANovartis Inst Biomed Res, MusculoSkeletal Dis, CH-4002 Basel, SwitzerlandMorphoSys AG, D-82152 Martinsried, Germany;